Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)31395-6
Abstract: Breast cancer is often treated with anthracyclines and HER2 inhibitors, which are well-known cardiotoxic agents. Cancer therapeutics related cardiac dysfunction (CTRCD) has been defined by most guidelines using arbitrary left ventricular ejection fraction (LVEF) cut-off…
read more here.
Keywords:
parameters predict;
cancer;
breast cancer;
echocardiographic parameters ... See more keywords